
Sign up to save your podcasts
Or
With human lives and global economies in mind, Pfizer CEO Albert Bourla has reallocated many of his company’s resources to focus on coronavirus. In conversation with CNBC’s Meg Tirrell, he discusses vaccine development, timeline, and cost
4.1
2020 ratings
With human lives and global economies in mind, Pfizer CEO Albert Bourla has reallocated many of his company’s resources to focus on coronavirus. In conversation with CNBC’s Meg Tirrell, he discusses vaccine development, timeline, and cost
4,085 Listeners
1,369 Listeners
240 Listeners
148 Listeners
329 Listeners
67 Listeners
660 Listeners
3,982 Listeners
154 Listeners
1,013 Listeners
317 Listeners
170 Listeners
2,088 Listeners
190 Listeners
591 Listeners
545 Listeners
59 Listeners
395 Listeners
402 Listeners
302 Listeners
120 Listeners
62 Listeners
23 Listeners
32 Listeners
11 Listeners
9 Listeners
265 Listeners
9 Listeners